Integrating cancer patients' perspectives into treatment decisions and treatment evaluation using patient-reported outcomes - A concept paper

European Journal of Cancer Care

Volumn 23, Issue 2, 2014, Pages 173-179

  Huebner, J ^a   Rose C ^b   Geissler, J ^c   Gleiter, C H ^d   Prott, F J ^e   Muenstedt, K ^f   Micke, O ^g   Muecke, R ^h,i   Buentzel, J ^j   Bottomley, A ^k,l   Hofheinz, R D ^m  

^a GOETHE UNIVERSITY   (Germany)

^b Centre d'Immunologie Pierre Fabre   (France)

^c CML Advocates ^*  (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e RNS Praxisgemeinschaft GbR   (Germany)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

^g FRANZISKUS HOSPITAL   (Germany)

^h LIPPE HOSPITAL   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j KKH Stollberg   (Germany)

^k EORTC DATA CENTER   (Belgium)

^l EORTC Headquarters   (Belgium)

^m UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

Clinical study; Individual patient's perspective; Patient reported outcome; Quality of life; Shared decision making; Treatment goals

Indexed keywords

DECISION MAKING; HUMAN; NEOPLASMS; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PATIENT PARTICIPATION; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE;

DECISION MAKING; HUMANS; NEOPLASMS; PATIENT CARE PLANNING; PATIENT OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84894865904     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12095     Document Type: Article

References (34)

1. Bridges J.F. (2003) Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Applied Health Economics and Health Policy 2, 213-224.
2. Efficace F., Biganzoli L., Piccart M., Coens C., Van Steen K., Cufer T., Coleman R.E., Calvert H.A., Gamucci T., Twelves C., Fargeot P. & Bottomley A. (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. European Journal of Cancer 40, 1021-1030.
3. FDA (2006) U.S. Department of Health and Human Services: Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims; December 2009. Available at: http://www.fda.gov/downloads/Drugs/Guidenaces/UCM193282.pdf (assessed 17 July 2013).
4. Frick E., Borasio G.D., Zehentner H., Fischer N. & Bumeder I. (2004) Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psycho-oncology 13, 116-124.
5. Frost M.H., Bonomi A.E., Estwing Ferrans C., Wong G.I. & Hays R.D. (2002) Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings 77, 488-494.
6. Frost M.H., Bonomi A.E., Cappelleri J.C., Schunemann H.J., Moynihan T.J. & Aaronson N.K. (2007) Applying quality-of life data formally and systematically into clinical practice. Mayo Clinic Proceedings 82, 1214-1228.
7. Gencer D., Tauchert F., Keilhauer N., Al-Batran S.E., Stahl M., Oskay-Özcelik G., Hipp M., Leibbrand B., Prasnikar N., Trarbach T., Stoll C., van Kampen M., Hochhaus A., Lorenzen S. & Hofheinz R.D. (2011) Cancer patients and the Internet: a survey of the 'Quality of Life' Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie. Onkologie 34, 435-440.
8. Gotay C.C. (2006) The prognostic value of QOL ratings in cancer patients: a systematic review. Podium Presentation at the 13th Annual Conference of the International Society for Quality of Life Research, Lisbon, Portugal, 10-14 October.
9. Gunnars B., Nygren P. & Glimelius B. (2001) Assessment of quality of life during chemotherapy. Acta Oncologica (Stockholm, Sweden) 40, 175-184.
10. Langendijk H., Aaronson N.K., de Jong J.M., ten Velde G.P., Muller M.J. & Wouters M. (2000) The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 55, 19-25.
11. Luckett T., Butow P.N. & King M.T. (2009) Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psycho-oncology 18, 1129-1138.
12. McCormack H.M., de L. Horne D.J. & Sheather S. (1988) Clinical applications of visual analogue scales: a critical review. Psychological Medicine 18, 1007-1019.
13. Montazeri A. (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes 7, 102.
14. Morris J., Perez D. & McNoe B. (1998) The use of quality of life data in clinical practice. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 7, 85-91.
15. Osoba D. (2000) Clinical meaningfulness (CM) of differences in health-related quality-of-life scores in clinical trials. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 9, 256-259.
16. Parliament M.B., Danjoux C.E. & Clayton T. (1985) Is cancer treatment toxicity accurately reported? International Journal of Radiation Oncology, Biology, Physics 11, 603-608.
17. Ribi K., Bernhard J., Schuller J.C., Weder W., Bodis S., Jörger M., Betticher D., Schmid R.A., Stupp R., Ris H.B. & Stahel R.A. (2008) Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer (Amsterdam, Netherlands) 61, 398-404.
18. Schwartz C.E., Bode R., Repucci N., Becker J., Sprangers M.A. & Fayers P.M. (2006) The clinical significance of adaptation. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 15, 1533-1550.
19. Simes R.J. & Coates A.S. (2001) Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? Journal of the National Cancer Institute. Monographs 30, 146-152.
20. Sprangers M.A. (2010) Disregarding clinical trial-based patient-reported outcomes is unwarranted: five advances to substantiate the scientific stringency of quality-of-life measurement. Acta Oncologica (Stockholm, Sweden) 49, 155-183.
21. Sprangers M.A. & Schwartz C.E. (1999a) Integrating response shift into health-related quality of life research: a theoretical model. Social Science and Medicine 48, 1507-1515.
22. Sprangers M.A. & Schwartz C.E. (1999b) The challenge of response shift for quality-of-life-based clinical oncology research. Annals of Oncology 10, 747-749.
23. Sprangers M.A., Van Dam F.S., Broersen J., Lodder L., Wever L., Visser M.R., Oosterveld P. & Smets E.M. (1999) Revealing response shift in longitudinal research on fatigue - the use of the thentest approach. Acta Oncologica (Stockholm, Sweden) 38, 709-718.
24. Stiel S., Psych D., Kues K., Krumm N., Radbruch L. & Elsner F. (2011) Assessment of quality of life in patients receiving palliative care: comparison of measurement tools and single item on subjective well-being. Journal of Palliative Medicine 14, 599-606.
25. Stone P.C., Murphy R.F., Matar H.E. & Almerie M.Q. (2008) Measuring the individual quality of life of patients with prostate cancer. Prostate Cancer and Prostatic Diseases 11, 390-396.
26. Tannock I.F., Osoba D., Stockler M.R., Ernst D.S., Neville A.J., Moore M.J., Armitage G.R., Wilson J.J., Venner P.M., Coppin C.M. & Murphy K.C. (1996) Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative endpoints. Journal of Clinical Oncology 14, 1756-1764.
27. Varricchio C.G. & Sloan J. (2002) The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer. Journal of the National Cancer Institute 94, 1184-1185.
28. Visser M.R., Oort F.J. & Sprangers M.A. (2005) Methods to detect response shift in quality of life data: a convergent validity study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 14, 629-649.
29. Waldron D., O'Boyle C.A., Kearney M., Moriarty M. & Carney D. (1999) Quality-of-life measurement in advanced cancer: assessing the individual. Journal of Clinical Oncology 17, 3603-3611.
30. Watkins Bruner D., Bryan C.J., Aaronson N., Blackmore C.C., Brundage M., Cella D., Ganz P.A., Gotay C., Hinds P.S., Kornblith A.B., Movsas B., Sloan J., Wenzel L. & Whalen G. (2007) Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-Sponsored Clinical Trials Networks. Journal of Clinical Oncology 25, 5051-5057.
31. Westerman M., Hak T., The A.M., Groen H. & van der Wal G. (2006) Problems eliciting cues in SEIQoL-DW: quality of life areas in small-cell lung cancer patients. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 15, 441-449.
32. Wettergren L., Kettis-Lindblad A., Sprangers M. & Ring L. (2009) The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 18, 737-746.
33. Wettergren L., Lindblad A.K., Glimelius B. & Ring L. (2011) Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer. Acta Oncologica (Stockholm, Sweden) 50, 648-652.
34. Wewers M.E. & Lowe N.K. (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing and Health 13, 227-236.